How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura?
Ann Blood
.
2023 Jun 30:8:11.
doi: 10.21037/aob-21-87.
Epub 2022 Apr 1.
Authors
Lucy Zheng
1
,
X Long Zheng
1
Affiliation
1
Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS, USA.
PMID:
37200543
PMCID:
PMC10187608
DOI:
10.21037/aob-21-87
No abstract available
Grants and funding
R01 HL126724/HL/NHLBI NIH HHS/United States
R01 HL144552/HL/NHLBI NIH HHS/United States
R01 HL157975/HL/NHLBI NIH HHS/United States